During the past decade, Coffs Harbour Health Campus conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 4 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 2 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Coffs Harbour Health Campus" #1 sponsor was "Australasian Gastro-Intestinal Trials Group" with 2 trials, followed by "ETOP IBCSG Partners Foundation" with 2 trials sponsored, "Arcus Biosciences, Inc." with 1 trials sponsored, "Breast Cancer Trials, Australia and New Zealand" with 1 trials sponsored and "Bristol-Myers Squibb" with 1 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Coffs Harbour Health Campus" #1 collaborator was "Academic and Community Cancer Research United" with 2 trials as a collaborator, "Breast International Group" with 2 trials as a collaborator, "Bristol-Myers Squibb" with 2 trials as a collaborator, "Canadian Cancer Trials Group" with 2 trials as a collaborator and "University of Sydney" with 2 trials as a collaborator. Other collaborators include 25 different institutions and companies that were collaborators in the rest 35 trials.

According to Clinical.Site data, the most researched conditions in "Coffs Harbour Health Campus" are "Breast Cancer" (3 trials), "Gastro-Oesophageal Cancer" (2 trials), "HER2-positive Breast Cancer" (2 trials), "Prostatic Neoplasms" (2 trials) and "Abiraterone Acetate" (1 trials). Many other conditions were trialed in "Coffs Harbour Health Campus" in a lesser frequency.

Most popular intervention types in "Coffs Harbour Health Campus" are "Drug" (15 trials), "Biological" (3 trials), "Other" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Nivolumab" (2 trials), "Paclitaxel" (2 trials), "Regorafenib" (2 trials) and "Abemaciclib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Coffs Harbour Health Campus" are 12 trials for "All" genders, 2 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Coffs Harbour Health Campus". undefined are not yet recruiting, 7 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Coffs Harbour Health Campus, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Coffs Harbour Health Campus, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".